Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
31/05 | 5,000 USD
+0,40% |
+0,40% |
C4X Discovery Holdings plc |
25/04 | 12,000 GBX
+27,32% |
+27,32% |
|
Cabaletta Bio Inc |
31/05 | 10,190 USD
+2,62% |
+2,62% |
|
Calithera Biosciences Inc |
31/05 | 0,010 USD
-50,00% |
-50,00% |
|
Calliditas Therapeutics AB |
31/05 | 39,990 USD
+3,95% |
+3,95% |
|
Cambridge Cognition Holdings plc |
31/05 | 42,000 GBX
+1,20% |
+1,20% |
|
Can B Corp |
31/05 | 0,016 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
31/05 | 2,360 USD
0,00% |
0,00% |
|
Capricor Therapeutics Inc |
31/05 | 5,680 USD
+2,34% |
+2,34% |
|
Cara Therapeutics Inc |
31/05 | 0,649 USD
+8,61% |
+8,61% |
Carbios |
31/05 | 25,750 EUR
+0,39% |
+0,39% |
Cardiol Therapeutics Inc - Class A |
31/05 | 3,570 CAD
+1,13% |
+1,13% |
|
Cardiovascular Systems Inc. |
27/04 | 20,000 USD
+0,15% |
+0,15% |
|
Caredx Inc |
31/05 | 13,010 USD
-3,77% |
-3,77% |
|
Carisma Therapeutics, Inc. |
31/05 | 1,330 USD
+1,53% |
+1,53% |
|
Carmat |
31/05 | 3,150 EUR
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
31/05 | 3,864 USD
+11,68% |
+11,68% |
|
Cassava Sciences Inc |
31/05 | 22,030 USD
-1,87% |
-1,87% |
|
Castle Biosciences Inc |
31/05 | 23,260 USD
-3,92% |
-3,92% |
|
Catalent Inc. |
31/05 | 53,790 USD
+0,34% |
+0,34% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
|
Catalyst Pharmaceuticals Inc |
31/05 | 16,170 USD
+0,37% |
+0,37% |
|
Ceapro Inc. |
31/05 | 0,225 CAD
-11,76% |
-11,76% |
|
Cel-Sci Corp. |
31/05 | 1,210 USD
0,00% |
0,00% |
|
Celldex Therapeutics Inc. |
31/05 | 33,300 USD
-0,95% |
-0,95% |
|
Cellectar Biosciences Inc |
31/05 | 3,090 USD
+1,64% |
+1,64% |
|
Cellectis |
31/05 | 2,710 USD
-0,11% |
-0,11% |
|
Cellectis |
31/05 | 2,410 EUR
-1,63% |
-1,63% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
Celyad Oncology |
31/05 | 0,304 EUR
-0,16% |
-0,16% |
|
Cerus Corp. |
31/05 | 1,790 USD
-2,19% |
-2,19% |
|
Champions Oncology Inc |
31/05 | 4,530 USD
+0,67% |
+0,67% |
|
Charlottes Web Holdings Inc |
31/05 | 0,220 CAD
-6,38% |
-6,38% |
|
Check-Cap Ltd |
31/05 | 2,295 USD
+0,14% |
+0,14% |
|
Checkpoint Therapeutics Inc |
31/05 | 1,900 USD
+0,53% |
+0,53% |
|
Chembio Diagnostics Inc. |
27/04 | 0,455 USD
+0,22% |
+0,22% |
|
Chimerix Inc |
31/05 | 0,967 USD
+0,30% |
+0,30% |
|
China Pharma Holdings Inc. |
31/05 | 0,296 USD
+1,51% |
+1,51% |
|
China SXT Pharmaceuticals Inc |
31/05 | 1,050 USD
-9,45% |
-9,45% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
31/05 | 12,690 USD
+2,17% |
+2,17% |
|
Cipher Pharmaceuticals Inc |
31/05 | 8,760 CAD
-2,56% |
-2,56% |
|
Citius Pharmaceuticals Inc |
31/05 | 0,698 USD
+6,39% |
+6,39% |
|
Clean Air Metals Inc |
31/05 | 0,050 CAD
0,00% |
0,00% |
|
ClearPoint Neuro Inc |
31/05 | 5,430 USD
-2,16% |
-2,16% |
|
Clearside Biomedical Inc |
31/05 | 1,400 USD
+0,72% |
+0,72% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Cns Pharmaceuticals Inc |
31/05 | 0,216 USD
-0,64% |
-0,64% |
|
Co-Diagnostics Inc |
31/05 | 1,050 USD
0,00% |
0,00% |
|
Cocrystal Pharma Inc |
31/05 | 2,250 USD
-4,66% |
-4,66% |
|
Codiak Biosciences Inc |
30/05 | 0,057 USD
0,00% |
0,00% |
|
Cogent Biosciences Inc |
31/05 | 8,010 USD
+9,88% |
+9,88% |
|
CohBar Inc |
31/05 | 0,810 USD
+6,56% |
+6,56% |
|
Coherus Biosciences Inc |
31/05 | 1,820 USD
-3,19% |
-3,19% |
|
Collegium Pharmaceutical Inc |
31/05 | 33,140 USD
+2,19% |
+2,19% |
|
CollPlant Biotechnologies Ltd |
31/05 | 5,605 USD
+1,91% |
+1,91% |
Coloplast |
31/05 | 824,800 DKK
-0,31% |
-0,31% |
|
Compass Pathways Plc |
31/05 | 7,380 USD
-0,54% |
-0,54% |
|
Compass Therapeutics Inc |
31/05 | 1,410 USD
+3,68% |
+3,68% |
|
Compugen Ltd. |
31/05 | 2,170 USD
-0,91% |
-0,91% |
|
Concert Pharmaceuticals Inc |
30/05 | 8,370 USD
0,00% |
0,00% |
|
Condor Technologies |
29/02 | 12,000 EUR
-4,00% |
-4,00% |
|
Conformis Inc. |
1/09 | 2,260 USD
0,00% |
0,00% |
|
Conmed Corp. |
31/05 | 76,440 USD
+1,00% |
+1,00% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Convatec Group |
31/05 | 248,600 GBX
-0,48% |
-0,48% |
|
Cooper Companies, Inc. |
31/05 | 94,310 USD
+4,52% |
+4,52% |
|
Cooper Companies, Inc. |
31/05 | 94,310 USD
+4,52% |
+4,52% |
|
Corbus Pharmaceuticals Holdings Inc |
31/05 | 42,800 USD
+3,13% |
+3,13% |
|
Corcept Therapeutics Inc |
31/05 | 30,170 USD
-3,33% |
-3,33% |
|
CorMedix Inc |
31/05 | 5,270 USD
-0,19% |
-0,19% |
|
Corvus Pharmaceuticals Inc |
31/05 | 2,160 USD
+2,37% |
+2,37% |
|
Covalon Technologies Ltd. |
31/05 | 2,180 CAD
+4,31% |
+4,31% |
|
Creo Medical Group Plc |
31/05 | 36,500 GBX
+3,55% |
+3,55% |
|
Crescita Therapeutics Inc |
27/05 | 0,420 CAD
-2,33% |
-2,33% |
|
Crinetics Pharmaceuticals Inc |
31/05 | 44,410 USD
-2,12% |
-2,12% |
|
CRISPR Therapeutics AG |
31/05 | 53,740 USD
-0,59% |
-0,59% |
|
Cronos Group Inc |
31/05 | 2,590 USD
+3,60% |
+3,60% |
|
Crossject |
31/05 | 2,310 EUR
-2,74% |
-2,74% |
|
Cryo-Cell International, Inc. |
31/05 | 8,220 USD
-6,70% |
-6,70% |
|
CTI BioPharma Corp |
23/06 | 9,090 USD
0,00% |
0,00% |
|
Cue Biopharma Inc |
31/05 | 1,630 USD
+2,52% |
+2,52% |
|
Cumberland Pharmaceuticals Inc. |
31/05 | 1,480 USD
+2,07% |
+2,07% |
|
CureVac N.V. |
31/05 | 3,890 USD
+3,18% |
+3,18% |
|
Curis Inc |
31/05 | 10,360 USD
-2,54% |
-2,54% |
|
Cutera Inc |
31/05 | 2,150 USD
+3,37% |
+3,37% |
|
Cyanotech Corp. |
31/05 | 0,305 USD
+1,67% |
+1,67% |
|
Cyclacel Pharmaceuticals Inc |
31/05 | 8,400 USD
+12,15% |
+12,15% |
|
Cyclacel Pharmaceuticals Inc |
31/05 | 2,640 USD
+30,69% |
+30,69% |
|
Cyclerion Therapeutics Inc |
31/05 | 2,670 USD
-2,91% |
-2,91% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
31/05 | 48,510 USD
-1,24% |
-1,24% |
|
CytomX Therapeutics Inc |
31/05 | 1,700 USD
-2,86% |
-2,86% |
|
Cytosorbents Corp |
31/05 | 0,900 USD
+2,28% |
+2,28% |
Cytotools AG |
31/05 | 0,540 EUR
+1,89% |
+1,89% |